Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
28
UHT Quote, Financials, Valuation and Earnings
Last price:
$38.73
Seasonality move
:
4.09%
Day range:
$38.91 - $39.77
52-week range:
$34.56 - $43.00
Dividend yield:
7.55%
P/E ratio:
30.28x
P/S ratio:
5.47x
P/B ratio:
3.43x
Volume:
212.8K
Avg. volume:
105.5K
1-year change:
5.37%
Market cap:
$544M
Revenue:
$99M
EPS (TTM):
$1.30
Analysts' Opinion
-
Consensus RatingUniversal Health Realty Income Trust has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $43.00, Universal Health Realty Income Trust has an estimated upside of 9.67% from its current price of $39.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $43.00 representing 100% downside risk from its current price of $39.21.
Fair Value
-
According to the consensus of 1 analyst, Universal Health Realty Income Trust has 9.67% upside to fair value with a price target of $43.00 per share.
UHT vs. S&P 500
-
Over the past 5 trading days, Universal Health Realty Income Trust has overperformed the S&P 500 by 1.08% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Universal Health Realty Income Trust does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Universal Health Realty Income Trust has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Universal Health Realty Income Trust reported revenues of $25.3M.
Earnings Growth
-
Universal Health Realty Income Trust has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Universal Health Realty Income Trust reported earnings per share of $0.29.
Enterprise value:
923.6M
EV / Invested capital:
--
Price / LTM sales:
5.47x
EV / EBIT:
19.07x
EV / Revenue:
9.30x
PEG ratio (5yr expected):
1.98x
EV / Free cash flow:
18.93x
Price / Operating cash flow:
11.14x
Enterprise value / EBITDA:
12.00x
Gross Profit (TTM):
$35.5M
Return On Assets:
3.12%
Net Income Margin (TTM):
18.06%
Return On Equity:
10.47%
Return On Invested Capital:
3.25%
Operating Margin:
36.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $95.4M | $98.7M | $99.4M | $24.5M | $25.3M | |
| Gross Profit | $33.1M | $35.8M | $35.5M | $8.5M | $8.4M | |
| Operating Income | $35.1M | $39.2M | $48.4M | $7M | $9.2M | |
| EBITDA | $62.1M | $67.1M | $77M | $14M | $17.1M | |
| Diluted EPS | $1.26 | $1.31 | $1.30 | $0.29 | $0.29 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $27.8M | $105.1M | $106.3M | $104.9M | $104.9M | |
| Total Assets | $517.7M | $609.3M | $607.9M | $584.3M | $568M | |
| Current Liabilities | $11.5M | $19.6M | $18.5M | $12M | $11.9M | |
| Total Liabilities | $365.9M | $375.7M | $397.6M | $402.7M | $409.5M | |
| Total Equity | $151.8M | $233.6M | $210.3M | $181.6M | $158.6M | |
| Total Debt | $343.1M | $351.8M | $371.8M | $378.3M | $386.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $45.4M | $43.3M | $48.8M | $9.4M | $10.3M | |
| Cash From Investing | -$26.2M | -$11.4M | -$15.8M | -$1.6M | -$1.9M | |
| Cash From Financing | -$19M | -$33.6M | -$32.7M | -$5.5M | -$8.1M | |
| Free Cash Flow | $45.4M | $43.3M | $48.8M | $9.4M | $10.3M | |
UHT
Sector
Market Cap
$544M
$974.8M
Price % of 52-Week High
91.19%
86.99%
Dividend Yield
7.55%
2.45%
Shareholder Yield
7.07%
3.12%
1-Year Price Total Return
5.38%
--
Beta (5-Year)
0.923
0.628
Dividend yield:
7.55%
Annualized payout:
$2.92
Payout ratio:
255.61%
Growth streak:
23 years
Technicals
8-day SMA
Sell
Level
$39.68
200-day SMA
Sell
Level
$39.58
Bollinger Bands (100)
Sell
Level
37.62 - 41.2
Chaikin Money Flow
Sell
Level
-172.6K
20-day SMA
Sell
Level
$40.75
Relative Strength Index (RSI14)
Sell
Level
40.99
ADX Line
Sell
Level
39.48
Williams %R
Buy
Level
-92.665
50-day SMA
Sell
Level
$39.59
MACD (12, 26)
Buy
Level
10.83
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Sell
Level
-640.1K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1371)
Sell
CA Score
(Annual)
Level (-0.8856)
Buy
Beneish M-Score
(Annual)
Level (-3.4763)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (1.4226)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Universal Health Realty Income Trust operates as a real estate investment trust. It engages in investing and leasing healthcare and human service facilities through direct ownership or joint ventures. The firm focuses on investing in acute care hospitals, behavioral health care hospitals, free-standing emergency departments, childcare centers, and medical or office buildings. The company was founded on December 24, 1986 and is headquartered in King of Prussia, PA.
Stock Forecast FAQ
In the current month, UHT has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The UHT average analyst price target in the past 3 months is $43.00.
-
Where Will Universal Health Realty Income Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Universal Health Realty Income Trust share price will rise to $43.00 per share over the next 12 months.
-
What Do Analysts Say About Universal Health Realty Income Trust?
Analysts are divided on their view about Universal Health Realty Income Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Universal Health Realty Income Trust is a Sell and believe this share price will drop from its current level to $43.00.
-
What Is Universal Health Realty Income Trust's Price Target?
The price target for Universal Health Realty Income Trust over the next 1-year time period is forecast to be $43.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is UHT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Universal Health Realty Income Trust is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of UHT?
You can purchase shares of Universal Health Realty Income Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Universal Health Realty Income Trust shares.
-
What Is The Universal Health Realty Income Trust Share Price Today?
Universal Health Realty Income Trust was last trading at $38.73 per share. This represents the most recent stock quote for Universal Health Realty Income Trust. Yesterday, Universal Health Realty Income Trust closed at $39.21 per share.
-
How To Buy Universal Health Realty Income Trust Stock Online?
In order to purchase Universal Health Realty Income Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get UHT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UHT
Sector
P/E ratio
30.28x
17.33x
PEG ratio
1.98x
0.05x
P/B ratio
3.43x
0.82x
Price / LTM sales
5.47x
3.14x
Growth Metrics
UHT
Sector
Revenue growth
3.3%
3.18%
Earnings growth
0.31%
6.29%
Revenue (5-year growth)
5.11%
2.86%
Earnings forecast
--
$0.14
Profitability
UHT
Sector
Profitability FY 2024
$36.8M
$154.7M
Return on invested capital
3.25%
2.03%
Return on assets
3.12%
1.83%
Return on equity
10.47%
3.5%
Earnings Date
Last Earnings Date
Oct
27
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Jan
26
Balance Sheet
UHT
Sector
Total cash
$6.9M
$73.8M
Short term investments
--
$11.9M
Total assets
$580.9M
$3.2B
Long term debt
$386.5M
$349.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.4% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.78% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 8.96% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
